김원구 부교수
#갑상선질환#갑상선암#내분비암
|
학력
2008 .03 ~ 2010 .02울산대학교 의학 박사
2006 .03 ~ 2008 .02울산대학교 의학 석사
1995 .03 ~ 2001 .02경북대학교 의학 학사
2006 .03 ~ 2008 .02울산대학교 의학 석사
1995 .03 ~ 2001 .02경북대학교 의학 학사
경력
2019 .03 ~ 2020 .02National Cancer Institute, National Institutes of Health Visiting Scholar
2018 .04 ~ 현재울산의대 서울아산병원 내분비내과 부교수
2013 ~ 2018 .03울산의대 서울아산병원 내분비내과 조교수
2010 .08 ~ 2013 .01National Cancer Institute, National Institutes of Health 박사 후 연구원
2010 .03 ~ 2010 .07서울아산병원 내분비내과 촉탁임상교수
2008 .03 ~ 2010 .02서울아산병원 내분비내과 임상강사 (Fellow)
2007 .03 ~ 2007 .08서울아산병원 내과 수석 전공의 (Chief Resident)
2004 .03 ~ 2008 .02서울아산병원 내과 전공의 (Resident)
2001 .03 ~ 2002 .02서울아산병원 수련의 (Intern)
2018 .04 ~ 현재울산의대 서울아산병원 내분비내과 부교수
2013 ~ 2018 .03울산의대 서울아산병원 내분비내과 조교수
2010 .08 ~ 2013 .01National Cancer Institute, National Institutes of Health 박사 후 연구원
2010 .03 ~ 2010 .07서울아산병원 내분비내과 촉탁임상교수
2008 .03 ~ 2010 .02서울아산병원 내분비내과 임상강사 (Fellow)
2007 .03 ~ 2007 .08서울아산병원 내과 수석 전공의 (Chief Resident)
2004 .03 ~ 2008 .02서울아산병원 내과 전공의 (Resident)
2001 .03 ~ 2002 .02서울아산병원 수련의 (Intern)
논문
Estimating the Growth Rate of Lung Metastases in Differentiated Thyroid Carcinoma: Response Evaluation
Criteria in Solid Tumors or Doubling Time?
Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer.
A Relook at the T Stage of Differentiated Thyroid Carcinoma with a Focus on Gross Extrathyroidal Extension.
Active Surveillance of Papillary Thyroid Microcarcinoma: Where Do We Stand?
Clinical Significance of Gross Invasion of Strap Muscles in Patients With 1- to 4-cm-Sized Papillary Thyroid Carcinoma Undergoing Lobectomy.
Determining Whether Tumor Volume Doubling Time and Growth Rate Can Predict Malignancy After Delayed Diagnostic Surgery of Follicular Neoplasm.
Expression of NF2 Modulates the Progression of BRAFV600E Mutated Thyroid Cancer Cells.
Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory
Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study.
Impact of delayed radioiodine therapy in intermediate-/high-risk papillary thyroid carcinoma.
Impact of tumor-associated macrophages and BRAFV600E mutation on clinical outcomes in patients with various thyroid cancers.
Long-term clinical outcomes of papillary thyroid carcinoma patients with biochemical incomplete response.
Low Lymphocyte-to-Monocyte Ratios Are Associated with Poor Overall Survival in Anaplastic Thyroid Carcinoma Patients.
Modified Transverse-Vertical Gross Examination: a Better Method for the Detection of Definite Capsular Invasion in Encapsulated Follicular-Patterned Thyroid Neoplasms.
Modified risk stratification based on cervical lymph node metastases following lobectomy for papillary thyroid carcinoma.
Mutational profile of papillary thyroid microcarcinoma with extensive lymph node metastasis.
Prognostic role of the lymphocyte-to-monocyte ratio for clinical outcomes of patients with progressive radioiodine-refractory differentiated thyroid carcinoma treated by sorafenib.
Quality of Life in Patients with Papillary Thyroid Microcarcinoma Managed by Active Surveillance or Lobectomy: A Cross-Sectional Study.
Recent Trends in the Clinicopathological Features of Thyroid Nodules in Pediatric Patients: A Single Tertiary Center Experience over 25 Years.
Risk of Malignancy According to the Sub-classification of Atypia of Undetermined Significance and Suspicious Follicular Neoplasm Categories in Thyroid Core Needle Biopsies.
Sex-Dependent Association between Weight Change and Thyroid Dysfunction: Population-Level Analysis
Using the Korean National Health and Nutrition Examination Survey.
The role of Slit2 as a tumor suppressor in thyroid cancer.
The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
Time trends of thyroglobulin antibody in ablated papillary thyroid carcinoma patients: Can we predict the rate of negative conversion?
Tumor Growth Rate Does Not Predict Malignancy in Surgically Resected Thyroid Nodules Classified as Bethesda Category III with Architectural Atypia.
Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Carcinoma.
A Follow-Up Strategy for Patients with an Excellent Response to Initial Therapy for Differentiated Thyroid Carcinoma: Less Is Better.
Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea.
Association Between Thyroid Dysfunction and Lipid Profiles Differs According to Age and Sex: Results from the Korean National Health and Nutrition Examination Survey.
Association between urinary sodium levels and iodine status in Korea.
BRAF and RAS Mutational Status in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Invasive Subtype of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma in Korea.
Criteria in Solid Tumors or Doubling Time?
Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer.
A Relook at the T Stage of Differentiated Thyroid Carcinoma with a Focus on Gross Extrathyroidal Extension.
Active Surveillance of Papillary Thyroid Microcarcinoma: Where Do We Stand?
Clinical Significance of Gross Invasion of Strap Muscles in Patients With 1- to 4-cm-Sized Papillary Thyroid Carcinoma Undergoing Lobectomy.
Determining Whether Tumor Volume Doubling Time and Growth Rate Can Predict Malignancy After Delayed Diagnostic Surgery of Follicular Neoplasm.
Expression of NF2 Modulates the Progression of BRAFV600E Mutated Thyroid Cancer Cells.
Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory
Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study.
Impact of delayed radioiodine therapy in intermediate-/high-risk papillary thyroid carcinoma.
Impact of tumor-associated macrophages and BRAFV600E mutation on clinical outcomes in patients with various thyroid cancers.
Long-term clinical outcomes of papillary thyroid carcinoma patients with biochemical incomplete response.
Low Lymphocyte-to-Monocyte Ratios Are Associated with Poor Overall Survival in Anaplastic Thyroid Carcinoma Patients.
Modified Transverse-Vertical Gross Examination: a Better Method for the Detection of Definite Capsular Invasion in Encapsulated Follicular-Patterned Thyroid Neoplasms.
Modified risk stratification based on cervical lymph node metastases following lobectomy for papillary thyroid carcinoma.
Mutational profile of papillary thyroid microcarcinoma with extensive lymph node metastasis.
Prognostic role of the lymphocyte-to-monocyte ratio for clinical outcomes of patients with progressive radioiodine-refractory differentiated thyroid carcinoma treated by sorafenib.
Quality of Life in Patients with Papillary Thyroid Microcarcinoma Managed by Active Surveillance or Lobectomy: A Cross-Sectional Study.
Recent Trends in the Clinicopathological Features of Thyroid Nodules in Pediatric Patients: A Single Tertiary Center Experience over 25 Years.
Risk of Malignancy According to the Sub-classification of Atypia of Undetermined Significance and Suspicious Follicular Neoplasm Categories in Thyroid Core Needle Biopsies.
Sex-Dependent Association between Weight Change and Thyroid Dysfunction: Population-Level Analysis
Using the Korean National Health and Nutrition Examination Survey.
The role of Slit2 as a tumor suppressor in thyroid cancer.
The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
Time trends of thyroglobulin antibody in ablated papillary thyroid carcinoma patients: Can we predict the rate of negative conversion?
Tumor Growth Rate Does Not Predict Malignancy in Surgically Resected Thyroid Nodules Classified as Bethesda Category III with Architectural Atypia.
Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Carcinoma.
A Follow-Up Strategy for Patients with an Excellent Response to Initial Therapy for Differentiated Thyroid Carcinoma: Less Is Better.
Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea.
Association Between Thyroid Dysfunction and Lipid Profiles Differs According to Age and Sex: Results from the Korean National Health and Nutrition Examination Survey.
Association between urinary sodium levels and iodine status in Korea.
BRAF and RAS Mutational Status in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Invasive Subtype of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma in Korea.
저서
저서 내용이 없습니다.
보도자료
[건강 팁] 갑상선 기능 항진증의 증상과 치료
https://www.sedaily.com/NewsView/1S28XR3ELM
올해도 건강검진 결과 받고 그냥 덮어두셨나요 [메디컬 인사이드]
http://www.seoul.co.kr/news/newsView.php?id=20190121023002&wlog_tag3=naver
유난히 더위 못 참아? 갑상선 항진증 의심
http://kormedi.com/1228430/
https://www.sedaily.com/NewsView/1S28XR3ELM
올해도 건강검진 결과 받고 그냥 덮어두셨나요 [메디컬 인사이드]
http://www.seoul.co.kr/news/newsView.php?id=20190121023002&wlog_tag3=naver
유난히 더위 못 참아? 갑상선 항진증 의심
http://kormedi.com/1228430/
포스팅
Clinical course of tracheoesophageal fistula after the use of Sorafenib for advanced thyroid cancer
Changing Trends in the Clinicopathological Features and Clinical Outcomes of Medullary Thyroid Carcinoma
Negative Expression of CPSF2 Predicts a Poorer Clinical Outcome in Patients with Papillary Thyroid Carcinoma
Low serum 25-hydroxy vitamin D3 levels are associated with higher prevalence of autoimmune thyroid disease
Changing Trends in the Clinicopathological Features and Clinical Outcomes of Medullary Thyroid Carcinoma
Negative Expression of CPSF2 Predicts a Poorer Clinical Outcome in Patients with Papillary Thyroid Carcinoma
Low serum 25-hydroxy vitamin D3 levels are associated with higher prevalence of autoimmune thyroid disease
영상자료
영상자료 내용이 없습니다.
발표자료
Strategies of Radioiodine Ablation in Patients with Small pT3N0M0 Differentiated Thyroid Cancer
SKI-606, a Src Inhibitor, Reduces Tumor Growth, Invasion, and Distant Metastasis in a Mouse Model of Thyroid Cancer
The effect of a XIAP inhibitor, Embelin, on apoptosis of thyroid cancer cell lines
The effect of a XIAP inhibitor, embelin, on apoptosis of thyroid cancer cell lines
Alpha-lipoic acid induces sodium iodide symporter (NIS) expression in TPC-1 thyroid cancer cell line
TSH 자극 갑상선 글로불린이 증가된 분화갑상선암 환자의 장기간 추적관찰 분석
The long-term clinical outcome of differentiated thyroid carcinoma patients who initially underwent total thyroidectomy and remnant ablation, and with undetectable stimulated thyroglobulin level one year after remnant ablation
Tho outcomes of adjuvant radioactive ablation therapy after reoperation for locoregioinally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation
The long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level at one year after initial treatment
Association between thyroid autoimmunity and helicobacter pylori infection
Long-term consequence of elevated stimulated serum thyroglobulin in differentiated thyroid cancer patients who initially underwent total thyroidectomy and remnant ablation
Adjuvant radioactive ablation therapy after reoperation for locoregionally recurrent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation
Anti-cancer effect of EGCG((-)-epigallocatechin-3-gallate) on thyroid cancer cell lines
The long-term clinical outcome of DTC patients who initially underwent total thyroidectomy and remnant ablation, and with undetectable stimulated thyroglobulin level one year after remnant ablation
Adjvant radioactive therapy after reoperation for locoregionally recurrent PTC in patients who initally underwent total thyroidectomy and high dose remnant ablation
Long-term consequence of elevated stimulated serum thyroglobulin in differentiated thyroid cancer patients who initially underwent total thyroidectomy and remnant ablation
The change of Characteristics for Korean Patients with Anaplastic Thyroid Carcinoma
X-linked inhibitor of apoptosis protein (XIAP) in papillary thyroid carcinoma
The outcome of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation
Follicular and hurthle cell carcinoma of the thyroid in iodine sufficient area: retrospective analysis of korean multicenter data
Clinical outcomes of re-operation for loco-regional recurrence of papillary thyroid carcinoma
Sunitinib이 정상 백서 갑상선 세포인 FRTL-5 세포에 미치는 영향
분화갑상선암 환자에서 방사성요오드 용량에 따른 방사성요오드 잔여갑상선제거술의 성공률 및 예후
재발된 갑상선 유두암 환자의 재수술 후 보조 방사성 요오드 치료의 효과
Empirical high dose radioiodine therapy is not useful in patients with positive thyroglobulin and negative nect ultrasonography and negative FDG-PET after initial therapy for papillary thyroid carcinoma
X-linked inhibitor of apoptosis in papillary thyroid carcinoma
Follicular and hurthle cell carcinoma of the thyroid gland in Korea
Effects of α-lipoic acid on differentiation of thyroid cancer cell
Clinical outcome of persistent radioiodine uptake on thyroid bed at diagnostic whole body scan in patients with differentiated thyroid carcinoma after initial surgery and remnant ablation; comparison between patients with second ablation and untreated patients
Empirical radioactive iodine therapy is not useful in patients with positive thyroglobulin and negative neck ultrasonography and negative FDG-PET after initial therapy for papillary thyroid carcinoma
SKI-606, a Src Inhibitor, Reduces Tumor Growth, Invasion, and Distant Metastasis in a Mouse Model of Thyroid Cancer
The effect of a XIAP inhibitor, Embelin, on apoptosis of thyroid cancer cell lines
The effect of a XIAP inhibitor, embelin, on apoptosis of thyroid cancer cell lines
Alpha-lipoic acid induces sodium iodide symporter (NIS) expression in TPC-1 thyroid cancer cell line
TSH 자극 갑상선 글로불린이 증가된 분화갑상선암 환자의 장기간 추적관찰 분석
The long-term clinical outcome of differentiated thyroid carcinoma patients who initially underwent total thyroidectomy and remnant ablation, and with undetectable stimulated thyroglobulin level one year after remnant ablation
Tho outcomes of adjuvant radioactive ablation therapy after reoperation for locoregioinally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation
The long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level at one year after initial treatment
Association between thyroid autoimmunity and helicobacter pylori infection
Long-term consequence of elevated stimulated serum thyroglobulin in differentiated thyroid cancer patients who initially underwent total thyroidectomy and remnant ablation
Adjuvant radioactive ablation therapy after reoperation for locoregionally recurrent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation
Anti-cancer effect of EGCG((-)-epigallocatechin-3-gallate) on thyroid cancer cell lines
The long-term clinical outcome of DTC patients who initially underwent total thyroidectomy and remnant ablation, and with undetectable stimulated thyroglobulin level one year after remnant ablation
Adjvant radioactive therapy after reoperation for locoregionally recurrent PTC in patients who initally underwent total thyroidectomy and high dose remnant ablation
Long-term consequence of elevated stimulated serum thyroglobulin in differentiated thyroid cancer patients who initially underwent total thyroidectomy and remnant ablation
The change of Characteristics for Korean Patients with Anaplastic Thyroid Carcinoma
X-linked inhibitor of apoptosis protein (XIAP) in papillary thyroid carcinoma
The outcome of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation
Follicular and hurthle cell carcinoma of the thyroid in iodine sufficient area: retrospective analysis of korean multicenter data
Clinical outcomes of re-operation for loco-regional recurrence of papillary thyroid carcinoma
Sunitinib이 정상 백서 갑상선 세포인 FRTL-5 세포에 미치는 영향
분화갑상선암 환자에서 방사성요오드 용량에 따른 방사성요오드 잔여갑상선제거술의 성공률 및 예후
재발된 갑상선 유두암 환자의 재수술 후 보조 방사성 요오드 치료의 효과
Empirical high dose radioiodine therapy is not useful in patients with positive thyroglobulin and negative nect ultrasonography and negative FDG-PET after initial therapy for papillary thyroid carcinoma
X-linked inhibitor of apoptosis in papillary thyroid carcinoma
Follicular and hurthle cell carcinoma of the thyroid gland in Korea
Effects of α-lipoic acid on differentiation of thyroid cancer cell
Clinical outcome of persistent radioiodine uptake on thyroid bed at diagnostic whole body scan in patients with differentiated thyroid carcinoma after initial surgery and remnant ablation; comparison between patients with second ablation and untreated patients
Empirical radioactive iodine therapy is not useful in patients with positive thyroglobulin and negative neck ultrasonography and negative FDG-PET after initial therapy for papillary thyroid carcinoma